|
|
|
|
|
|
By Erin Harris, editor-in-chief, Cell & Gene | Raj Bandaru, Associate Director in Regulatory Affairs and U.S. Regulatory Affairs Lead at Accenture provides rich context on parts of the recent FDA Draft Guidance, Rare Diseases: Considerations For The Development Of Drugs And Biological Products. |
|
|
|
|
Improvements in delivery systems can help ensure that the editing machinery reaches the target cells efficiently, reducing the likelihood of off-target effects in non-target cells. |
|
|
|
|
|
|
| Cell Culture Solutions To Unlock Your Cell Performance | Webinar | Nucleus Biologics | Gain insight into an innovative approach to cell culture media development, and learn about the journey a cell therapy company underwent to accelerate the development of their cell-based therapeutic. |
|
|
| Transforming T Cell Manufacturing Via Elutriation | Application Note | Invetech | This study demonstrates the Korus platform's ability to reduce manufacturing variability by elutriating lymphocytes from apheresis, providing a more consistent cell product for downstream manufacturing. |
|
|
|
|
|
|
|
|
|
|
|
|
|
Connect With Cell & Gene: |
|
|
|